Department of Pathology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Department of Oncology, The Sol Goldman Pancreatic Cancer Research Center, Johns Hopkins University School of Medicine, Baltimore, Maryland.
Am J Pathol. 2018 Jul;188(7):1723-1733. doi: 10.1016/j.ajpath.2018.03.012. Epub 2018 Apr 22.
To obtain a better understanding of the genetic alterations of high-grade pancreatic intraepithelial neoplasia (HG-PanIN), we performed whole-genome copy number analysis by using single nucleotide polymorphism microarrays and targeted next-generation sequencing of 11 microdissected HG-PanIN and two low-grade PanIN lesions associated with HG-PanIN. HG-PanIN mutation profiles were compared with those of their associated invasive pancreatic ductal adenocarcinoma. All PanIN lesions harbored somatic KRAS mutations. The most common copy number losses in the HG-PanIN were at the CDKN2A (9p21), TP53 (17p13), and SMAD4 (18q21) loci. Chromosomal losses in HG-PanIN were also found at 6p25-p24, 6q11-q27, 12q24, and 17q23-q24. Biallelic inactivation of CDKN2A and TP53 was detected in five of eight and in three of eight evaluable PanIN lesions, respectively. None of the HG-PanIN lesions had SMAD4 mutations or homozygous deletion. Copy number gains were noted at the MYC (8q24) and CCNE1 (19q12) loci and at 1q25-q31. Four HG-PanINs and one low-grade PanIN harbored chromothripsis-like regions. Five of seven pancreatic ductal adenocarcinomas evaluated had additional mutations that were not found in their associated HG-PanIN. HG-PanIN harbors widespread copy number alterations and commonly shows evidence of biallelic inactivation of CDKN2A and TP53 but not SMAD4. Chromothripsis events contribute to the copy number alterations of HG-PanIN.
为了更好地了解高级胰腺上皮内瘤变(HG-PanIN)的基因改变,我们通过使用单核苷酸多态性微阵列和 11 个微切割的 HG-PanIN 和与 HG-PanIN 相关的两个低级别 PanIN 病变的靶向下一代测序进行了全基因组拷贝数分析。HG-PanIN 突变谱与相关侵袭性胰腺导管腺癌进行了比较。所有 PanIN 病变均携带体细胞 KRAS 突变。HG-PanIN 中最常见的拷贝数缺失是在 CDKN2A(9p21)、TP53(17p13)和 SMAD4(18q21)基因座。HG-PanIN 中还发现染色体丢失在 6p25-p24、6q11-q27、12q24 和 17q23-q24。在 8 个可评估 PanIN 病变中的 5 个和 8 个可评估 PanIN 病变中的 3 个中分别检测到 CDKN2A 和 TP53 的双等位基因失活。没有 HG-PanIN 病变具有 SMAD4 突变或纯合缺失。在 MYC(8q24)和 CCNE1(19q12)基因座和 1q25-q31 处观察到拷贝数增益。4 个 HG-PanIN 和 1 个低级别 PanIN 具有类染色体重排区域。在评估的 7 个胰腺导管腺癌中有 5 个具有未在其相关的 HG-PanIN 中发现的额外突变。HG-PanIN 具有广泛的拷贝数改变,通常显示 CDKN2A 和 TP53 的双等位基因失活证据,但没有 SMAD4。染色体重排事件导致 HG-PanIN 的拷贝数改变。